Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
4
×
life sciences
national blog main
boston blog main
boston top stories
san diego blog main
biotech
boston
drugs
dyne therapeutics
fda
myotonic dystrophy type 1
national top stories
new york blog main
rare disease drugs
san diego top stories
san francisco blog main
akcea therapeutics
anylam pharmaceuticals
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech ipos
bluebird bio
cannabidiol
cardiomyopathy
dravet syndrome
duchenne muscular dystrophy
epidiolex
facioscapulohumeral muscular dystrophy
fen-phen
fenfluramine
gene therapy
gw pharmaceuticals
inotersen
joshua brumm
kaleido biosciences
lennox-gastaut syndrome
metacrine
What
drug
rare
4
×
ago
genetic
medicines
approved
battle
data
dyne
fda
ipo
muscle
sets
therapeutics
akcea
alnylam
amyloidosis
attr
available
biotechs
brings
cannabis
company
considering
debilitating
derivative
developing
disease
diseases
disorders
dyne’s
early
epilepsy
expected
experimental
eyes
form
gw
gw’s
having
Language
unset
Current search:
rare
×
" clinical trials "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug